Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.200
-0.010 (-0.83%)
At close: Feb 11, 2026, 4:00 PM EST
1.200
0.00 (0.00%)
Pre-market: Feb 12, 2026, 4:52 AM EST
Lucid Diagnostics Revenue
Lucid Diagnostics had revenue of $1.21M in the quarter ending September 30, 2025, with 3.33% growth. This brings the company's revenue in the last twelve months to $4.40M, up 5.01% year-over-year. In the year 2024, Lucid Diagnostics had annual revenue of $4.35M with 79.00% growth.
Revenue (ttm)
$4.40M
Revenue Growth
+5.01%
P/S Ratio
22.83
Revenue / Employee
$61,097
Employees
72
Market Cap
165.22M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.35M | 1.92M | 79.00% |
| Dec 31, 2023 | 2.43M | 2.05M | 544.03% |
| Dec 31, 2022 | 377.00K | -123.00K | -24.60% |
| Dec 31, 2021 | 500.00K | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Inogen | 347.03M |
| Treace Medical Concepts | 218.88M |
| InfuSystem Holdings | 141.05M |
| AVITA Medical | 72.40M |
| LENSAR | 59.14M |
| CVRx, Inc. | 55.97M |
| Apyx Medical | 47.90M |
| SANUWAVE Health | 41.28M |
LUCD News
- 7 days ago - PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities - PRNewsWire
- 21 days ago - Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard® - PRNewsWire
- 2 months ago - Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection - PRNewsWire
- 2 months ago - Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree - PRNewsWire
- 3 months ago - Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - PRNewsWire
- 3 months ago - PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results - PRNewsWire
- 3 months ago - Lucid Diagnostics Inc. (LUCD) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results - PRNewsWire